Report copyright - Review of Biosimilar Trials and Data on Adalimumab in ... · Stable MTX, adalimumab naive, no more than 1 previous biologic 55.9 81 9.4 24.1 14.4 1.49 Weinblatt 2018 n =544 52 weeks
Please pass captcha verification before submit form